Drugs / C11 Methionine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02646085 | Jul 2016 → Jun 2021 | plasma cell myeloma | Yingbing Wang | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C11 Methionine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02646085 ↗ |
| Modality | Diagnostic / imaging agent | “diagnostic positron emission tomography imaging after intravenous injection of C11 Methionine” NCT02646085 ↗ |
| Route | Intravenous | “injected intravenously” NCT02646085 ↗ |